Role of NKG2D in immune responses to tumors
Role of NKG2D in immune responses to tumors
批准号:
7152866
负责人:
DAVID H RAULET
金额:
$25.35万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-12-31 至 2008-06-30
关键词:
Activated Natural Killer CellAnimalsCD8B1 geneCancer VaccinesCell Surface ProteinsCell physiologyCellsCytotoxic T-LymphocytesDevelopmentFamilyGene TargetingHumanImmuneImmune responseImmune systemImmunityImmunologic MonitoringImmunotherapeutic agentImmunotherapyLigandsLinkMalignant NeoplasmsMedical SurveillanceMusNK Cell ActivationNatural Killer CellsNatureNormal CellPlayProtein IsoformsProteinsReactionRoleSentinelSpecificityStressSystemT-LymphocyteTestingTherapeuticTumor AntigensTumor Cell Linebasecancer immunotherapycellular transductionin vivomacrophageneoplastic cellreceptorresearch studyresponsetranslational studytumortumor growth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The proposal is to investigate the function of the NKG2D immunoreceptor in immune responses to tumor
cells. NKG2D is a stimulatory receptor expressed by all natural killer (NK) cells, all activated cytotoxic T cells
(CTL) all activated macrophages, and fractions of gamma/delta T cells and NK1.1+ T cells. NKG2D
recognizes several related cell surface proteins (ligands), including Rael and H60. Expression of high levels
of NKG2D ligands by target cells results in a strong attack by NK cells and activated macrophages, and an
enhanced response of CTL to tumor-specific antigens. Most normal cells do not express these NKG2D
ligands. Most tumor cell lines, in contrast, upregulate Rael and other NKG2D ligands. The hypothesis to be
tested is that NKG2D and its ligands represent a system for tumor immunosurveillance. That is, it is
proposed that NKG2D ligands are normally upregulated in developing tumor cells as a means to alert and
activate the immune system, and that the resulting immune response serves to limit the development and/or
growth of tumors in normal animals. This hypothesis will be tested using several approaches. In addition,
preliminary experiments demonstrate that tumor cell lines transduced to express high levels of NKG2D
ligands, when irradiated, function as potent therapeutic cancer vaccines that stimulate an effective immune
response against established tumors of the same type (but not transduced). Therefore, studies will be
undertaken to establish how effective this approach is and whether it can be effectively combined with other
immunotherapies.
Specific Aim 1: To determine the role of NKG2D isoforms associated with different adapter molecules in
stimulating and costimulating NKG2D+ cells.
Specific Aim 2: To generate and characterize gone targeted mice lacking NKG2D expression.
Specific Aim 3. To assess the importance of NKG2D in surveillance of tumors in vivo.
Specific Aim 4. To determine the efficacy of NKG2D stimulation as a cancer immunotherapy
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms underlying combination therapy mobilizing NK cells
-
批准号:10623188
-
项目类别:
-
资助金额:$46.54万
-
财政年份:2022
-
负责人:DAVID H RAULET
-
依托单位:
STING-dependent activation of Natural Killer cells by viral and tumor DNA
-
批准号:10561647
-
项目类别:
-
资助金额:$45.3万
-
财政年份:2014
-
负责人:DAVID H RAULET
-
依托单位:
STING-dependent activation of Natural Killer cells by viral and tumor DNA
-
批准号:10352399
-
项目类别:
-
资助金额:$45.3万
-
财政年份:2014
-
负责人:DAVID H RAULET
-
依托单位:
STING-dependent activation of Natural Killer cells by viral and tumor DNA
-
批准号:9888196
-
项目类别:
-
资助金额:$36.29万
-
财政年份:2014
-
负责人:DAVID H RAULET
-
依托单位:
STING-dependent activation of Natural Killer cells by viral and tumor DNA
-
批准号:9895895
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2014
-
负责人:DAVID H RAULET
-
依托单位:
STING-dependent activation of Natural Killer cells by viral and tumor DNA
-
批准号:8851516
-
项目类别:
-
资助金额:$38.32万
-
财政年份:2014
-
负责人:DAVID H RAULET
-
依托单位:
STING-dependent activation of Natural Killer cells by viral and tumor DNA
-
批准号:8755504
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2014
-
负责人:DAVID H RAULET
-
依托单位:
Immunology & Pathogenesis Program Training Grant
-
批准号:8337573
-
项目类别:
-
资助金额:$27.37万
-
财政年份:2012
-
负责人:DAVID H RAULET
-
依托单位:
Induction of NK-cell ligands by viruses
-
批准号:7081707
-
项目类别:
-
资助金额:$28.99万
-
财政年份:2006
-
负责人:DAVID H RAULET
-
依托单位:
Role of NKG2D in immune responses to turmors
-
批准号:8259460
-
项目类别:
-
资助金额:$25.88万
-
财政年份:2002
-
负责人:DAVID H RAULET
-
依托单位:
Role of NKG2D in immune responses to tumors
-
批准号:6575797
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2002
-
负责人:DAVID H RAULET
-
依托单位:
Role of NKG2D in immune responses to turmors
-
批准号:7524931
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2002
-
负责人:DAVID H RAULET
-
依托单位:
Role of NKG2D in immune responses to turmors
-
批准号:7647158
-
项目类别:
-
资助金额:$26.68万
-
财政年份:2002
-
负责人:DAVID H RAULET
-
依托单位:
Role of NKG2D in immune responses to turmors
-
批准号:7849026
-
项目类别:
-
资助金额:$26.68万
-
财政年份:2002
-
负责人:DAVID H RAULET
-
依托单位:
Role of NKG2D in immune responses to tumors
-
批准号:8883398
-
项目类别:
-
资助金额:$27.43万
-
财政年份:2002
-
负责人:DAVID H RAULET
-
依托单位:
Role of NKG2D in immune responses to tumors
-
批准号:6986817
-
项目类别:
-
资助金额:$26.14万
-
财政年份:2002
-
负责人:DAVID H RAULET
-
依托单位:
Role of NKG2D in immune responses to tumors
-
批准号:6831633
-
项目类别:
-
资助金额:$26.79万
-
财政年份:2002
-
负责人:DAVID H RAULET
-
依托单位:
Role of NKG2D in immune responses to tumors
-
批准号:6694028
-
项目类别:
-
资助金额:$26.81万
-
财政年份:2002
-
负责人:DAVID H RAULET
-
依托单位:
Role of NKG2D in immune responses to turmors
-
批准号:8071216
-
项目类别:
-
资助金额:$25.88万
-
财政年份:2002
-
负责人:DAVID H RAULET
-
依托单位:
Role of NKG2D in immune responses to tumors
-
批准号:9066094
-
项目类别:
-
资助金额:$27.41万
-
财政年份:2002
-
负责人:DAVID H RAULET
-
依托单位:
海外基金